EuroAPI Logo

EuroAPI

Develops and manufactures APIs and provides CDMO services for complex molecules.

EAPI | PA

Overview

Corporate Details

ISIN(s):
FR0014008VX5 (+2 more)
LEI:
9695002FT7GGI3CKKJ14
Country:
France
Address:
15 RUE TRAVERSIERE, 75012 PARIS

Description

EuroAPI is a developer and manufacturer of Active Pharmaceutical Ingredients (APIs), focusing on small and complex molecules. The company's business is centered on two main activities: offering API solutions from its large portfolio and providing Contract Development and Manufacturing Organization (CDMO) services. The product portfolio contains over 200 ingredients, with expertise in categories such as opiates and controlled substances, prostaglandins, corticoids, hormones, anti-infectives, and Vitamin B12. As a CDMO, EuroAPI provides services for complex chemistry, including small molecule synthesis, microbial fermentation, particle engineering (micronization and spray drying), and the development of lipids and tides like oligonucleotides, serving a global customer base.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-01-06 17:40
EUROAPI welcomes the French Minister for Health and Access to Healthcare Yannic…
English 717.5 KB
2024-12-09 20:17
EUROAPI entame un nouveau chapitre avec une nouvelle gouvernance et un nouveau …
French 546.0 KB
2024-12-09 20:17
EUROAPI moves into a new chapter with new Governance and Leadership
English 720.5 KB
2024-10-16 07:00
Olivier Falut est nommé Directeur financier d’EUROAPI
French 527.6 KB
2024-10-16 07:00
Olivier Falut appointed EUROAPI’s Chief Financial Officer
English 701.9 KB
2024-10-15 17:45
EUROAPI clôt le financement de son plan FOCUS-27
French 521.5 KB
2024-10-15 17:45
EUROAPI closes the financing of its FOCUS-27 plan
English 517.5 KB
2024-10-10 20:38
EUROAPI finalise le financement de son plan FOCUS-27 et poursuit son exécution
French 559.4 KB
2024-10-10 20:38
EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its…
English 558.9 KB
2024-08-05 08:00
EUROAPI - Availability of 2024 Half-Year Financial Report
English 390.2 KB
2024-08-05 08:00
EUROAPI - Mise à disposition du Rapport financier semestriel 2024
French 447.1 KB
2024-08-02 00:00
Rapport Financier Semestriel 2024
French 2.6 MB
2024-07-30 17:45
RESULTATS DU PREMIER SEMESTRE 2024 - Le plan stratégique Focus-27 est en bonne …
French 386.8 KB
2024-07-30 17:45
H1 2024 Results - Focus-27 strategic plan on track with timely execution of the…
English 476.4 KB
2024-06-26 17:40
EUROAPI poursuit sa transformation grâce au plan FOCUS-27 et pose les bases d’u…
French 246.6 KB

Automate Your Workflow. Get a real-time feed of all EuroAPI filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EuroAPI

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EuroAPI via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.